Rheumatology Doctors in Farmington Hills, MI Accepting Medicare

7 Rheumatology doctors found. Showing 1 - 7

Dr. Parveen Qazi, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 32255 Northwestern Hwy Ste 120, Farmington Hills, MI 48334 Phone: 248-350-3190    Fax: 248-350-3245

Paul E Wenig, DO Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 28100 Grand River Ave, Suite 206, Farmington Hills, MI 48336 Phone: 248-471-1549    Fax: 248-478-1827

Dr. Larry J Silverman, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 32255 Northwestern Hwy Ste 120, Farmington Hills, MI 48334 Phone: 248-350-3190    Fax: 248-350-3245

Dr. Sabrina Masooda Qazi, D.O Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 32255 Northwestern Hwy, Suit 120, Farmington Hills, MI 48334 Phone: 248-350-3190    Fax: 248-350-3245

Dr. Ashwini Mugulvaly Shadakshari, M. D Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 28100 Grand River Ave Ste 314, Farmington Hills, MI 48336 Phone: 248-471-1549

Dr. Henry Brystowski, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 32255 Northwestern Hwy Ste 120, Farmington Hills, MI 48334 Phone: 248-350-3190    Fax: 248-350-3245

Inocencio A Cuesta, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 28100 Grand River Ave Ste 314, Farmington Hills, MI 48336 Phone: 248-471-1549    Fax: 248-478-1827

News Archive

Study shows why candidate vaccine used in HVTN 505 clinical trial not protective against HIV infection

A study by researchers at the National Institute of Allergy and Infectious Diseases and Duke University helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection despite robustly inducing anti-HIV antibodies: the vaccine stimulated antibodies that recognized HIV as well as microbes commonly found in the intestinal tract, part of the body's microbiome.

Orexo third quarter net revenues decrease to MSEK 35.9

"During the third quarter, Abstral™ sales were 480% higher than in the same period last year. Sales of Edluar™, Orexo's sublingual zolpidem treatment for insomnia, continue to grow more strongly from a low base, with new stock being ordered for the first time since launch and generating royalty income for Orexo.

Over 12,000 courses of lung cancer treatment completed with Accuray's CyberKnife radiosurgery

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that more than 12,000 courses of lung cancer treatment have been completed with CyberKnife radiosurgery. Usage of CyberKnife radiosurgery for lung cancer continues to grow, as illustrated by a 25 percent increase year over year in calendar year 2009.

RemitDATA launches TITAN to solve healthcare transparency problem

RemitDATA, an expert in reimbursement, productivity and utilization solutions in outpatient healthcare, today launched TITAN, a new, data-rich solution that provides a real-time, transparent view of essential business metrics.

Drug delivery still has great development potential

Nanocapsules and other containers can transport drugs through a patient's body directly to the origin of the disease and release them there in a controlled manner. Such sophisticated systems are occasionally used in cancer therapy. Because they work very specifically, they have fewer side effects than drugs that are distributed throughout the entire organism.

Read more Medical News

› Verified 8 days ago